Evidence map›Paper›PMID 26656766›Full record

Trial reportPhysiology & behavior2016

Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers.

Maria J van Kooten, Maria G Veldhuizen, Ivan E de Araujo, Stephanie S O'Malley, Dana M Small

Abstract readClinical Trial
In one paragraph

Trial report in Physiology & behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. DRD2: Bridging the Genome and Ingestive Behavior.Trends in cognitive sciences · 2017
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Maria J van KootenThe John B Pierce Laboratory, 290 Congress Ave, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George St, New Haven, CT 06511, USA; University of Groningen, Faculty of Medical Sciences, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Maria G VeldhuizenThe John B Pierce Laboratory, 290 Congress Ave, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George St, New Haven, CT 06511, USA.
Ivan E de AraujoThe John B Pierce Laboratory, 290 Congress Ave, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George St, New Haven, CT 06511, USA.
Stephanie S O'MalleyDepartment of Psychiatry, Yale University School of Medicine, 300 George St, New Haven, CT 06511, USA.
Dana M SmallThe John B Pierce Laboratory, 290 Congress Ave, New Haven, CT 06519, USA; Department of Psychiatry, Yale University School of Medicine, 300 George St, New Haven, CT 06511, USA; University of Cologne, Albertus-Magnus-Platz, 09235 Köln, Germany. Electronic address: dana.small@yale.edu.
Yale University · USUniversity of Cologne · DEUniversity of Groningen · NL

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI Matthew J Girgenti · 2001 to 2026
$43.7M
Improving Alcoholism TreatmentK05AA014715 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2013
$2.1M
Neural circuitry of sweet tasteR01DC014859 · NIDCD · JOHN B. PIERCE LABORATORY, INC. · PI DE ARAUJO, IVAN E · 2015 to 2019
$1.5M
NIAAA NIH HHS K05 AA014715NIAAA NIH HHS P50 AA012870NIAAA NIH HHS P50AA012870NIAAA NIH HHS P50 K05AA014715NIDCD NIH HHS R01 DC014859NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

Compromised dopamine signaling in the striatum has been associated with the expression of impulsive behaviors in addiction, obesity and alcoholism. In rodents, intragastric infusion of the fatty acid amide oleoylethanolamide increases striatal extracellular dopamine levels via vagal afferent signaling. Here we tested whether supplementation with PhosphoLean™, a dietary supplement that contains the precursor of the fatty acid amide oleoylethanolamide (N-oleyl-phosphatidylethanolamine), would reduce impulsive responding and alcohol use in heavy drinking young adults. Twenty-two individuals were assigned to a three-week supplementation regimen with PhosphoLean™ or placebo. Impulsivity was assessed with self-report questionnaires and behavioral tasks pre- and post-supplementation. Although self-report measures of impulsivity did not change, supplementation with PhosphoLean™, but not placebo, significantly reduced false alarm rate on a Go/No-Go task. In addition, an association was found between improved sensitivity on the Go/No-Go task and reduced alcohol intake. These findings provide preliminary evidence that promoting fatty acid derived gut-brain dopamine communication may have therapeutic potential for reducing impulsivity in heavy drinkers.

Indexed as

Dietary SupplementsAdultAlcohol DrinkingAlcohol-Related DisordersDouble-Blind MethodEndocannabinoidsFemaleHumansImpulsive BehaviorInhibition, PsychologicalMaleMiddle AgedOleic AcidsPsychomotor PerformanceSelf ReportTreatment OutcomeEndocannabinoidsOleic AcidsoleoylethanolamideAlcoholDopamineGo/No-Go taskImpulsivityInhibitory controlOEA

Identifiers

PMID26656766
PMCPMC4718847
OpenAlexW2189493192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.